Efficacy of the non-adenosine analogue A1 adenosine receptor agonist (BR-4935) on cardiovascular function after cardiopulmonary bypass

Thoracic and Cardiovascular Surgeon

Volumn 58, Issue 2, 2010, Pages 86-92

  Veres, G ^a,d   Radovits, T ^a   Otila, G ^a   Hirschberg, K ^a,d   Haider, H ^a   Krieger, N ^a   Knoll, A ^b   Weigang, E ^c   Szabolcs, Z ^d   Karck, M ^a   Szabo G ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b BAYER PHARMA AG   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Cardiovascular surgery; Coronary bypass surgery; Myocardial protection

Indexed keywords

ACETYLCHOLINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE TRIPHOSPHATE; BR 4935; MALONALDEHYDE; NITROPRUSSIDE SODIUM; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; DRUG EFFICACY; HEART ARREST; HEART VENTRICLE CONTRACTION; HEART VENTRICLE FUNCTION; HEMODYNAMICS; INDUCED HYPOTHERMIA; NONHUMAN; PRIORITY JOURNAL; VASODILATATION;

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; AMINOPYRINE; ANIMALS; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; CORONARY CIRCULATION; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DOGS; ENDOTHELIUM, VASCULAR; MALONDIALDEHYDE; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; NITROPRUSSIDE; PEROXIDASE; RECEPTOR, ADENOSINE A1; RECOVERY OF FUNCTION; VASODILATION; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 77949992047     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-0029-1186271     Document Type: Article

References (33)

1. Wallace A, Lam H W., Nosé P S., Bellows W, Mangano D T. Changes in systolic and diastolic ventricular function with cold cardioplegic arrest in man. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group. J Card Surg 1994 9 (Suppl.3) 497-502
2. Forman M B., Velasco C E. Role of adenosine in the treatment of myocardial stunning. Cardiovasc Drugs Ther 1991 5 (5) 901-908
3. Ely S W., Berne R M. Protective effects of adenosine in myocardial ischemia. Circulation 1992 85 (3) 893-904
4. Shryock J C., Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol 1997 79 (12) 2-10
5. Yaar R, Jones M R., Chen J F., Ravid K. Animal models for the study of adenosine receptor function. J Cell Physiol 2005 202 (1) 9-20
6. Thornton J D., Liu G S., Olsson R A., Downey J M. Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction. Circulation 1992 85 (2) 659-665
7. Toombs C F., McGee S, Johnston W E., Vinten-Johansen J. Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation 1992 86 (3) 986-994
8. Lasley R D., Rhee J W., Van Wylen D G., Mentzer Jr R M. Adenosine A1 receptor mediated protection of the globally ischemic isolated rat heart. J Mol Cell Cardiol 1990 22 (1) 39-47
9. Liu G S., Thornton J, Van Winkle D M., Stanley A W., Olsson R A., Downey J M. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 1991 84 (1) 350-356
10. Van Winkle D M., Chein G L., Wolff R A., Soifer B E., Kuzume K, Davis R F. Cardioprotection provided by adenosine receptor activation is abolished by blockade of the KATP channel. Am J Physiol 1994 266 (2 Pt 2) H829-H839
11. Auchampach J A., Gross G J. Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs. Am J Physiol 1993 264 (5 Pt 2) H1327-H1336
12. Rosentreter U, Kraemer T, Shimada M et al. Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same. Patent Pub No. WO/2003/053441.
13. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki L M. Apoptosis in human acute myocardial infarction. Circulation 1997 95 (2) 320-323
14. Murry C E., Jennings R B., Reimer K A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986 74 (5) 1124-1136
15. Yellon D M., Downey J M. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 2003 83 (4) 1113-1151
16. Baines C P., Cohen M V., Downey J M. Signal transduction in ischemic preconditioning: the role of kinases and mitochondrial K(ATP) channels. J Cardiovasc Electrophysiol 1999 10 (5) 741-754
17. Miura T, Liu Y, Kita H, Ogawa T, Shimamoto K. Roles of mitochondrial ATP-sensitive K channels and PKC in anti-infarct tolerance afforded by adenosine A1 receptor activation. J Am Coll Cardiol 2000 35 (1) 238-245
18. Louttit J B., Hunt A A., Maxwell M P., Drew G M. The time course of cardioprotection induced by GR79236, a selective adenosine A1-receptor agonist, in myocardial ischaemia-reperfusion injury in the pig. J Cardiovasc Pharmacol 1999 33 (2) 285-291
19. Finegan B A., Lopaschuk G D., Gandhi M, Clanachan A S. Inhibition of glycolysis and enhanced mechanical function of working rat hearts as a result of adenosine A1 receptor stimulation during reperfusion following ischaemia. Br J Pharmacol 1996 118 (2) 355-363
20. Bolling S F., Bies L E., Gallagher K P., Bove E L. Enhanced myocardial protection with adenosine. Ann Thorac Surg 1989 47 (6) 809-815
21. Parker P E., Bashour F A., Downey H F., Boutros I S. Coronary reperfusion: effects of vasodilators (papaverine and adenosine). Am Heart J 1977 93 (1) 66-72
22. Cox B F., Greenland B D., Perrone M H., Merkel L A. Ischaemia/reperfusion selectively attenuates coronary vasodilatation to an adenosine A2- but not to an A1-agonist in the dog. Br J Pharmacol 1994 111 (4) 1233-1239
23. Vanden Hoek T, Becker L B., Shao Z H., Li C Q., Schumacker P T. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ Res 2000 86 (5) 541-548
24. Narayan P, Mentzer Jr R M., Lasley R D. Adenosine A1 receptor activation reduces reactive oxygen species and attenuates stunning in ventricular myocytes. J Mol Cell Cardiol 2001 33 (1) 121-129
25. Jordan J E., Zhao Z Q., Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 1999 43 (4) 860-878
26. Loria V, Dato I, Graziani F, Biasucci L M. Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes. Mediators Inflamm 2008 DOI: 10.1155/2008/135625
27. Budde J M., Morris C D., Velez D A. et al. Reduction of infarct size and preservation of endothelial function by multidose intravenous adenosine during extended reperfusion. J Surg Res 2004 116 (1) 104-115
28. Schmitt J P., Schröder J, Schunkert H, Birnbaum D E., Aebert H. Role of apoptosis in myocardial stunning after open heart surgery. Ann Thorac Surg 2002 73 (4) 1229-1235
29. Shalaby A, Rinne T, Jrvinen O et al. Initial results of a clinical study: adenosine enhanced cardioprotection and its effect on cardiomyocytes apoptosis during coronary artery bypass grafting. Eur J Cardiothorac Surg 2008 33 (4) 639-644
30. Lee H T., LaFaro R J., Reed G E. Pretreatment of human myocardium with adenosine during open heart surgery. J Card Surg 1995 10 (6) 665-676
31. Mentzer Jr R M., Birjiniuk V, Khuri S et al. Adenosine myocardial protection: preliminary results of a phase II clinical trial. Ann Surg 1999 229 (5) 643-649 discussion 649-650
32. Cohen G, Feder-Elituv R, Iazetta J et al. Phase 2 studies of adenosine cardioplegia. Circulation 1998 98 (Suppl.19) II225-II233
33. Teoh L K., Grant R, Hulf J A., Pugsley W B., Yellon D M. The effect of preconditioning (ischemic and pharmacological) on myocardial necrosis following coronary artery bypass graft surgery. Cardiovasc Res 2002 53 (1) 175-180